SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...

SUNNYVALE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- BioCardia (BCDA), Inc. , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today ...

Myocardial infarction that results from chronic ischemia and its effects—cell loss and formation of fibrous tissue—can lead to left ventricular remodeling, aneurysm formation, and the development of ...

Tsukuba, Japan—Acute myocardial infarction and acute kidney injury are life-threatening conditions caused by ischemia, resulting from reduced or blocked blood flow to organs. Although early ...

Please provide your email address to receive an email when new articles are posted on . Hallum and colleagues used linked data from multiple Danish registers to identify 1,157,666 women who had a live ...

Atherosclerotic coronary artery disease (CAD) affects the coronary arteries, which deliver blood to the myocardium. CAD symptoms include stable angina, reviewed here, and acute coronary syndromes (ACS ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

TORONTO, May 2, 2013 /PRNewswire/ -- CellAegis Devices, Inc., announced today the first clinical trial program in the European Union to evaluate the use of the Company's autoRIC™ Device for Chronic ...

Vascular. 2005;13(2):84-91. The most common causes of injury in the present series were lacerations from either accidental, occupational, or road traffic injuries. Stab injuries and missile injuries ...